Media & Resources

IAVI leaders to represent the full breadth of TB vaccine research, development, implementation, advocacy, and policy at the 7th Global Forum in Rio.

From HIV vaccine development to socio-behavioral research and community engagement in clinical trials, IAVI leaders are presenting on a range of pressing topics in HIV prevention research.

Researchers at three sites are vaccinating participants for Lassa fever, an emerging infectious disease with outbreaks in the region.

IAVI leaders will present on why we still need an HIV vaccine and how to engage communities in clinical trials and will launch an Action Plan for accelerating progress on broadly neutralizing antibodies for HIV prevention.

New life sciences building to welcome IAVI’s emerging infectious disease vaccine research team.

With creativity and commitment, changing the status quo to enable access to promising new technologies is possible.

A series of publications highlight advancements in countermeasures for Lassa fever, an animal-borne illness.

In this episode of Meet the Scientist, we explore IAVI’s efforts in the late-stage development of the MTBVAC TB vaccine candidate.